NOTICE: The Canada Post Strike has ended. Orders are now flowing through our Canadian Pharmacies again. Please contact us for additional information.
search

Advair Diskus

FLUTICASONE PROPIONATE/SALMETEROL XINAFOATE
*The product shipped may have different packaging depending on supplier/strength chosen

Advair Diskus

REQUIRED
FLUTICASONE PROPIONATE/SALMETEROL XINAFOATE
Select Strength
GENERIC
United Kingdom
Product Approved for Sale in the United Kingdom Manufactured by: Various Generic Manufacturers
Drug:
Fluticasone/Salmeterol Inhalation Powder 100mcg/50mcg
Manufacturer:
Mylan Pharmaceutical
Approved for Sale in:
Canada
Canada
Fluticasone/Salmeterol Inhalation Powder 100mcg/50mcg
Mylan Pharmaceutical
Canada
Canada
BRAND
United Kingdom
Marketed as Seretide Accuhaler in the United Kingdom Manufactured by: Allen & Hanburys
Drug:
Advair Diskus 100mcg/50mcg
Manufacturer:
Glaxosmithkline
Approved for Sale in:
New Zealand
New Zealand
Advair Diskus 100mcg/50mcg
Glaxosmithkline
New Zealand
New Zealand
Drug:
Advair Diskus 100mcg/50mcg
Manufacturer:
Glaxosmithkline
Approved for Sale in:
Canada
Canada
Advair Diskus 100mcg/50mcg
Glaxosmithkline
Canada
Canada
SWITCH & SAVE
Take advantage of our generic equivalent everyday low prices
SWITCH & SAVE
Take advantage of our generic equivalent everyday low prices

Select Quantity
Other Advair Diskus Options for Purchase:
Type
Product
Manufacturer
Country
Qty-price (USD)
Drug:
Fluticasone/Salmeterol Inhalation Powder 100mcg/50mcg
Manufacturer:
Mylan Pharmaceutical
Approved for Sale in:
Canada
Canada
Fluticasone/Salmeterol Inhalation Powder 100mcg/50mcg
Mylan Pharmaceutical
Canada
Canada
Drug:
Advair Diskus 100mcg/50mcg
Manufacturer:
Glaxosmithkline
Approved for Sale in:
New Zealand
New Zealand
Advair Diskus 100mcg/50mcg
Glaxosmithkline
New Zealand
New Zealand
Drug:
Advair Diskus 100mcg/50mcg
Manufacturer:
Glaxosmithkline
Approved for Sale in:
Canada
Canada
Advair Diskus 100mcg/50mcg
Glaxosmithkline
Canada
Canada

Advair Diskus: Dual Action Relief for Asthma and COPD

Advair Diskus combines two powerful medications, fluticasone and salmeterol, to provide comprehensive relief for individuals suffering from asthma and chronic obstructive pulmonary disease (COPD). Fluticasone is a corticosteroid that reduces inflammation in the airways, while salmeterol is a long-acting bronchodilator that helps to relax the muscles around the airways, making breathing easier. This dual-action inhaler is designed to be used daily, offering long-term management and control of symptoms, so you can breathe more freely and live a more active life.

Easy-to-Use Inhaler for Consistent, Long-Term Control

Advair Diskus is engineered for ease of use, making it simple for patients to incorporate it into their daily routine. The pre-loaded inhaler provides a precise dose of medication with each use, ensuring consistent and reliable treatment. With its intuitive design, the Advair Diskus allows for quick and effective delivery of medication to the lungs, helping you maintain control over your asthma or COPD symptoms throughout the day. Regular use of Advair Diskus can lead to fewer flare-ups and a noticeable improvement in your breathing comfort.

Proven Efficacy in Reducing Asthma and COPD Exacerbations

Advair Diskus is clinically proven to reduce the frequency of asthma attacks and COPD exacerbations, making it a key component in managing these chronic conditions. By addressing both the inflammation and muscle constriction in the airways, Advair Diskus provides comprehensive protection against sudden breathing difficulties. Patients who use Advair Diskus as prescribed are less likely to experience severe symptoms, leading to fewer emergency visits and a better quality of life. Trust in the proven efficacy of Advair Diskus to keep your respiratory condition under control.